新锐医药国际控股有限公司（香港联交所代码：06108）于2026年4月2日发布截至2026年3月31日的月报表。报告显示，公司本月并未出现任何新增股份发行、回购或注销活动，整体股本结构维持不变。
报告期内，公司法定股本维持15,000,000,000股，面值为每股0.01港元，合计法定股本总额为150,000,000港元；已发行股份总数为200,616,665股，与上月保持一致，同时未出现库存股。期内，公司根据于2013年10月25日采纳的购股权计划所授出的股份期权数量为12,820,000份，亦与之前持平，没有任何行使或失效记录。
公司声称将继续遵守香港联交所《上市规则》及其他相关法律法规的要求。公告由公司秘书吴日升签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.